<DOC>
	<DOCNO>NCT01719874</DOCNO>
	<brief_summary>The purpose study determine safety efficacy TCN-032 give healthy adult volunteer inoculate influenza A virus</brief_summary>
	<brief_title>Influenza Virus Challenge Study Test Monoclonal Antibody TCN-032 Treatment Influenza</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Age 18 45 year , inclusive . In good health history major medical condition Female subject must pregnant nursing Have vaccinate influenza virus since 2006 Serosusceptible challenge virus Nonsmoker current smoker willing/able desist Presence significant acute chronic , uncontrolled medical psychiatric illness History evidence autoimmune disease Any history adulthood asthma , history COPD , pulmonary hypertension , reactive airway disease , chronic lung condition etiology ) , use bronchodilator asthma medication within adulthood History clinical evidence recurrent low respiratory tract infection Positive human immunodeficiency virus ( HIV ) , hepatitis B ( HBV ) , hepatitis C ( HCV ) antibody screen Subject diabetic History frequent epistaxis ( nose bleeds ) Any nasal sinus surgery within 6 month screen visit Recent and/or recurrent history autonomic dysfunction ( fainting , palpitation , etc . ) Any laboratory test , ECG spirometry abnormal deem Investigator ( ) clinically significant . Any acute medical condition significant past medical history hepatic , renal , cardiovascular , pulmonary , gastrointestinal , haematological , locomotor , immunologic , ophthalmologic , metabolic , endocrine , diseases Major surgery within 3 month prior screen visit Evidence drug abuse positive urine Class A drug alcohol screen prior admission Subjects symptomatic hay fever Subjects history significant adverse reactions/allergies History allergy intolerance oseltamivir zanamivir . Health care worker ( include doctor , nurse , medical student , ally healthcare professional ) anticipate patient contact within 2 week viral challenge .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Influenza</keyword>
	<keyword>monoclonal antibody</keyword>
</DOC>